Dog /

Breed profile · FDA CVM July 2026 extract

Greyhound adverse-event record

Adverse-event filings for Greyhound (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#55 of 510
by report volume (all breeds)
3,717
FDA CVM reports on file
3.8%
death-coded share of reports
#189 of 275
by death-coded share (≥50 reports)

How the 3,717 reports break down

By recorded gender -- every report on file for Greyhound, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 398 298.5 199 99.5 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Greyhound drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Greyhound ranks #55 of 510 by total reports (3,717) and #189 of 275 by death-coded share (3.8%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#55
This breed, reports of 510
#189
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Greyhound has 3,717 reports now versus 3,685 in that prior snapshot: 32 more (0.9%).

Report change
+32
Death-coded reports
+1
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Greyhound changes

Total Reports

3,717

High report volume

Deaths Reported

140

of 3,717 reports

Death-coded share of reports

3.8%

Below-median death-coded share

Avg Age at Report

5.4 yr

30.9 kg avg weight

Breed Safety Scorecard

C+ (61/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate B
3.8%

Share of reports coded as a fatality

Euthanasia rate A-
1.5%

Share of reports resulting in euthanasia

Full recovery rate F
15.6%

Share of reports coded "Recovered/Normal"

5-year trend A
-41%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Greyhound death-coded reports 3.8%
Cross-breed median

3.8% of 3,717 greyhound reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Greyhound's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

4% 31st percentile Higher share than 31% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Greyhound 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Greyhound among report-volume vs. death-rate peers

Every breed shown has at least 50 filed reports. Volume reflects how often a breed is reported, not how common it is; death rate is the share of a breed's own reports coded as a death outcome.

Source: FDA openFDA Animal & Veterinary Adverse Events database 2×2 strategic matrix plotting 30 entities by Total Reports (X) and Death Rate (%) (Y), with a crosshair dividing the plot into four quadrants. High volume, high death rateLow volume, high death rateHigh volume, low death rateLow volume, low death rate 020,00040,00060,00080,000100,000 0%5%10%15% Total Reports Death Rate (%) Greyhound vs. all breeds, report volume and death-coded share Retriever - Labrador-93675, 3.7%Crossbred Canine/dog-70591, 3.2%Domestic Shorthair-65226, 7.2%Dog (unknown)-48820, 8.8%Retriever - Golden-35980, 3.7%Shepherd Dog - German-32220, 4.4%Chihuahua-31521, 4.2%Terrier - Yorkshire-24924, 3.7%Shih Tzu-24405, 3.6%Boxer (German Boxer)-19405, 4.4%Beagle-17970, 3.6%Pit Bull-17865, 3.1%Shepherd Dog - Australian-16274, 3.7%Terrier (unspecified)-14058, 3.1%Maltese-13940, 3.2%Dachshund (unspecified)-13512, 4.6%Cat (unknown)-13248, 9.3%Terrier - Jack Russell-10423, 3.7%Collie - Border-10130, 4.3%Siberian Husky-9811, 4.5%Domestic Longhair-9615, 7%Pug-9224, 5.2%Spitz - German Pomeranian-9086, 4.9%Terrier - Bull - American Pit-8769, 4.7%Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog)-7871, 3.6%Terrier - Boston-7737, 4.5%Spaniel - Cocker American-7640, 4%Domestic (unspecified)-7576, 13.4%Poodle (unspecified)-7534, 3.4%Schnauzer - Miniature-7513, 4.4%
Source: FDA openFDA Animal & Veterinary Adverse Events database
Average weight at time of report: 30.9 kg (68.1 lbs)

Top Reported Reactions

Lack of efficacy (endoparasite) - hookworm 1,353
INEFFECTIVE, HOOKS 874
Digestive tract disorder NOS 528
Diarrhoea 327
Vomiting 245
Lack of efficacy - NOS 214
Lethargy (see also Central nervous system depression in 'Neurological') 170
Lack of efficacy (endoparasite) - NOS 132
Emesis 112
Loose stool 85
Anorexia 73
Other abnormal test result NOS 72
Death 67
Death by euthanasia 66
Bloody diarrhoea 61

Most Referenced Drugs

Ivermectin + Pyrantel As Pamoate Salt 872
Moxidectin 382
Milbemycin Oxime + Praziquantel 313
Imidacloprid + Moxidectin 265
Milbemycin Oxime + Spinosad 247
Ivermectin/Pyrantel Pamoate Chewable 272Mcg/652Mg 147
Fenbendazole 133
Pyrantel Pamoate;Sarolaner 132
Febantel + Praziquantel + Pyrantel Pamoate 116
Ivermectin, Pyrantel 104
Afoxolaner 93
Bedinvetmab 80
Milbemycin Oxime 76
Febantel + Praziquantel + Pyrantel 76
Carprofen 72

Outcome Breakdown

Outcome Unknown
1,837 (53.0%)
Ongoing
872 (25.1%)
Recovered/Normal
580 (16.7%)
Died
85 (2.5%)
Euthanized
56 (1.6%)
Recovered with Sequela
39 (1.1%)

Gender Distribution

Female 1,938 (52.1%)
Male 1,644 (44.2%)
Unknown 113 (3.0%)
Mixed 22 (0.6%)

Reports by Year

Year Reports Trend
2010 149
2011 130
2012 183
2013 198
2014 185
2015 195
2016 255
2017 398
2018 411
2019 398
2020 326
2021 247
2022 170
2023 155
2024 155
2025 146
2026 16

Greyhound: low death-coded share in the FDA CVM extract

Signature read: 3,717 reports place Greyhound in the upper third of breed filing volume (#55 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Greyhound sits at #55 of 510 by report volume among all breeds and #49 of 298 among dog breeds, with 3,717 reports and 140 (3.8%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #189 of 275. Mean age at report: 5.4 years, average weight 30.9 kg (68.1 lbs).

Top reported signs: Lack of efficacy (endoparasite) - hookworm (1,353), INEFFECTIVE, HOOKS (874), Digestive tract disorder NOS (528). Most-referenced drug: Ivermectin + Pyrantel As Pamoate Salt (872 reports), followed by Moxidectin (382) and Milbemycin Oxime + Praziquantel (313).

Outcome coding on 3,469 status-recorded reports is dominated by Outcome Unknown (53.0%). Annual submissions ranged 16-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

High-volume peer sets for Greyhound drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (3.8% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (30.9 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Greyhound?
There are 3,717 adverse event reports involving Greyhound in the FDA database, of which 140 were death-coded (3.8% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Greyhound ranks #55 of 510 by report volume among all breeds PlainBreed indexes (#49 of 298 among dog breeds).
Where does Greyhound sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Greyhound is #55 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #49 of 298. Among breeds with at least 50 reports, its death-coded share ranks #189 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Greyhound?
The most commonly reported adverse reactions for Greyhound are Lack of efficacy (endoparasite) - hookworm (1,353 reports), INEFFECTIVE, HOOKS (874 reports), Digestive tract disorder NOS (528 reports), Diarrhoea (327 reports), Vomiting (245 reports).
What drugs are most frequently associated with Greyhound adverse events?
The drugs most frequently referenced in Greyhound adverse event reports are Ivermectin + Pyrantel As Pamoate Salt (872 reports), Moxidectin (382 reports), Milbemycin Oxime + Praziquantel (313 reports), Imidacloprid + Moxidectin (265 reports), Milbemycin Oxime + Spinosad (247 reports).
What is the average age of Greyhound in adverse event reports?
The average age of Greyhound at the time of adverse event reports is 5.4 years, with an average weight of 30.9 kg (68.1 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Greyhound (Dog), extract as of July 2026 extract. 3,717 reports · 140 death-coded (3.8% of reports, not a mortality rate) · #55 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →